ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Mergers & Acquisitions

Evonik makes moves in medical market

by Michael McCoy
September 6, 2019 | APPEARED IN VOLUME 97, ISSUE 35

 

With two deals, Evonik Industries is pushing further into the medical materials market. The specialty chemical maker has acquired from Canada’s Interface Biologics surface-modification technology based on low-molecular-weight fluorooligomers that enhance medical devices’ biocompatibility. Separately, Evonik has invested in the 3-D printing start-up Meditool. The Shanghai-based firm—representing Evonik Venture Capital’s first direct investment in China—makes implants for neuro and spine surgery.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment